Renier Brentjens
RB
Renier Brentjens
Co-founder
Rate
About
Co-founder of Juno Therapeutics. Pioneer of CAR-T cell immunotherapy, first to publish efficacy in adult acute lymphoblastic leukemia. Spent 20+ years at Memorial Sloan Kettering. Winner of 2024 Warren Alpert Prize.
Frequently asked
Who is Renier Brentjens?
Co-founder of Juno Therapeutics. Pioneer of CAR-T cell immunotherapy, first to publish efficacy in adult acute lymphoblastic leukemia. Spent 20+ years at Memorial Sloan Kettering. Winner of 2024 Warren Alpert Prize.
What is Renier Brentjens's current role?
Renier Brentjens is currently Co-founder.
Where is Renier Brentjens based?
Renier Brentjens is based in Buffalo, United States.
Comments
No comments yet. Be the first to share your take.
Profile
About Renier Brentjens
Renier Brentjens is Co-founder. Renier is a founder of Juno Therapeutics. Based in Buffalo, United States. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.